Old Web
English
Sign In
Acemap
>
authorDetail
>
V. DePril
V. DePril
Melanoma
Ipilimumab
Medicine
Pathology
Oncology
6
Papers
218
Citations
0.03
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the effect of systemic corticosteroids for the treatment of immune-related adverse events (irAEs) on the development or maintenance of ipilimumab clinical activity
2016
Journal of Clinical Oncology
Asim Amin
V. DePril
Omid Hamid
J. Wolchock
Michele Maio
Bart Neyns
Kevin M. Chin
Ramy Ibrahim
Axel Hoos
S. ODay
Show All
Source
Cite
Save
Citations (34)
Effectiveness of treatment guidance on diarrhea and colitis across ipilimumab studies.
2011
Journal of Clinical Oncology
S. ODay
Jeffrey S. Weber
Jedd D. Wolchok
Jon M. Richards
Paul Lorigan
David F. McDermott
Walter J. Urba
V. DePril
K. N. Heller
Ramy Ibrahim
A. Hauschild
Show All
Source
Cite
Save
Citations (25)
Efficacy and safety of ipilimumab induction and maintenance dosing in patients with advanced melanoma who progressed on one or more prior therapies
2008
Journal of Clinical Oncology
S. ODay
Ramy Ibrahim
V. DePril
Michele Maio
Vanna Chiarion Sileni
Thomas F. Gajewski
Hubert Pehamberger
Axel Hoos
Rachel Humphrey
J. Wolchock
Show All
Source
Cite
Save
Citations (32)
Antitumor response and new lesions in advanced melanoma patients on ipilimumab treatment
2008
Journal of Clinical Oncology
Jedd D. Wolchok
Ramy Ibrahim
V. DePril
Michele Maio
Paola Queirolo
Kaan Harmankaya
Lotta Lundgren
Axel Hoos
Rachel Humphrey
Omid Hamid
Show All
Source
Cite
Save
Citations (23)
1